BNTC
Benitec Biopharma Inc. (BNTC)
NASDAQ · Healthcare
Benitec Biopharma Inc. annual/quarterly total liabilities history from 2019 to 2024. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Benitec Biopharma Inc. total liabilities for the quarter ending June 30, 2024 were 5.0M, a 16.42% increase year-over-year.
- Benitec Biopharma Inc. total liabilities for 2024 were 5.0M, a 16.42% increase from 2023.
- Benitec Biopharma Inc. total liabilities for 2023 were 4.3M, a 37.88% increase from 2022.
- Benitec Biopharma Inc. total liabilities for 2022 were 3.1M, a 125.79% increase from 2021.
- Benitec Biopharma Inc. total liabilities for 2021 were 1.4M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Benitec Biopharma Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2024 | $5 |
| 2023 | $4 |
| 2022 | $3 |
| 2021 | $1 |
| 2020 | $1 |
| 2019 | $3 |
| Benitec Biopharma Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2024-06-30 | $5 |
| 2023-06-30 | $4 |
| 2022-06-30 | $3 |
| 2021-06-30 | $1 |
| 2020-06-30 | $1 |
| 2019-06-30 | $3 |
Benitec Biopharma Inc. Total Liabilities — FAQ
Benitec Biopharma Inc. (BNTC) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BNTC's total liabilities history?
The chart and table above show Benitec Biopharma Inc.'s total liabilities by year and by quarter, including the growth rate.